233 related articles for article (PubMed ID: 23678609)
21. Granulomatous pneumonitis associated with adult-onset Blau-like syndrome.
Yao Q; Piliang M; Nicolacakis K; Arrossi A
Am J Respir Crit Care Med; 2012 Sep; 186(5):465-6. PubMed ID: 22942351
[No Abstract] [Full Text] [Related]
22. Blau syndrome-associated Nod2 mutation alters expression of full-length NOD2 and limits responses to muramyl dipeptide in knock-in mice.
Dugan J; Griffiths E; Snow P; Rosenzweig H; Lee E; Brown B; Carr DW; Rose C; Rosenbaum J; Davey MP
J Immunol; 2015 Jan; 194(1):349-57. PubMed ID: 25429073
[TBL] [Abstract][Full Text] [Related]
23. Nod2-Nodosome in a Cell-Free System: Implications in Pathogenesis and Drug Discovery for Blau Syndrome and Early-Onset Sarcoidosis.
Iwasaki T; Kaneko N; Ito Y; Takeda H; Sawasaki T; Heike T; Migita K; Agematsu K; Kawakami A; Morikawa S; Mokuda S; Kurata M; Masumoto J
ScientificWorldJournal; 2016; 2016():2597376. PubMed ID: 27403452
[TBL] [Abstract][Full Text] [Related]
24. NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort.
Aróstegui JI; Arnal C; Merino R; Modesto C; Antonia Carballo M; Moreno P; García-Consuegra J; Naranjo A; Ramos E; de Paz P; Rius J; Plaza S; Yagüe J
Arthritis Rheum; 2007 Nov; 56(11):3805-13. PubMed ID: 17968944
[TBL] [Abstract][Full Text] [Related]
25. Blau syndrome, clinical and genetic aspects.
Sfriso P; Caso F; Tognon S; Galozzi P; Gava A; Punzi L
Autoimmun Rev; 2012 Nov; 12(1):44-51. PubMed ID: 22884558
[TBL] [Abstract][Full Text] [Related]
26. Blau arteritis resembling Takayasu disease with a novel NOD2 mutation.
Khubchandani RP; Hasija R; Touitou I; Khemani C; Wouters CH; Rose CD
J Rheumatol; 2012 Sep; 39(9):1888-92. PubMed ID: 22859352
[TBL] [Abstract][Full Text] [Related]
27. Potential Benefits of TNF Targeting Therapy in Blau Syndrome, a NOD2-Associated Systemic Autoinflammatory Granulomatosis.
Matsuda T; Kambe N; Takimoto-Ito R; Ueki Y; Nakamizo S; Saito MK; Takei S; Kanazawa N
Front Immunol; 2022; 13():895765. PubMed ID: 35711422
[TBL] [Abstract][Full Text] [Related]
28. Blau syndrome mutation of CARD15/NOD2 in sporadic early onset granulomatous arthritis.
Rosé CD; Doyle TM; McIlvain-Simpson G; Coffman JE; Rosenbaum JT; Davey MP; Martin TM
J Rheumatol; 2005 Feb; 32(2):373-5. PubMed ID: 15693102
[TBL] [Abstract][Full Text] [Related]
29. Thalidomide dramatically improves the symptoms of early-onset sarcoidosis/Blau syndrome: its possible action and mechanism.
Yasui K; Yashiro M; Tsuge M; Manki A; Takemoto K; Yamamoto M; Morishima T
Arthritis Rheum; 2010 Jan; 62(1):250-7. PubMed ID: 20039400
[TBL] [Abstract][Full Text] [Related]
30. Brief Report: First Identification of Intrafamilial Recurrence of Blau Syndrome due to Gonosomal NOD2 Mosaicism.
Mensa-Vilaro A; Cham WT; Tang SP; Lim SC; González-Roca E; Ruiz-Ortiz E; Ariffin R; Yagüe J; Aróstegui JI
Arthritis Rheumatol; 2016 Apr; 68(4):1039-44. PubMed ID: 26606664
[TBL] [Abstract][Full Text] [Related]
31. A Novel Pathogenic
Rodrigues FG; Petrushkin H; Webster AR; Bickerstaff M; Moraitis E; Rowczenio D; Aróstegui JI; Westcott M
Ophthalmic Genet; 2021 Dec; 42(6):753-764. PubMed ID: 34251956
[TBL] [Abstract][Full Text] [Related]
32. Blau syndrome: cross-sectional data from a multicentre study of clinical, radiological and functional outcomes.
Rosé CD; Pans S; Casteels I; Anton J; Bader-Meunier B; Brissaud P; Cimaz R; Espada G; Fernandez-Martin J; Hachulla E; Harjacek M; Khubchandani R; Mackensen F; Merino R; Naranjo A; Oliveira-Knupp S; Pajot C; Russo R; Thomée C; Vastert S; Wulffraat N; Arostegui JI; Foley KP; Bertin J; Wouters CH
Rheumatology (Oxford); 2015 Jun; 54(6):1008-16. PubMed ID: 25416713
[TBL] [Abstract][Full Text] [Related]
33. Somatic NOD2 mosaicism in Blau syndrome.
de Inocencio J; Mensa-Vilaro A; Tejada-Palacios P; Enriquez-Merayo E; González-Roca E; Magri G; Ruiz-Ortiz E; Cerutti A; Yagüe J; Aróstegui JI
J Allergy Clin Immunol; 2015 Aug; 136(2):484-7.e2. PubMed ID: 25724124
[No Abstract] [Full Text] [Related]
34. Blau syndrome.
Martin J; Kodjikian L; Duquesne A; Le Scanff J; Sève P
QJM; 2011 Nov; 104(11):997-8. PubMed ID: 20947513
[No Abstract] [Full Text] [Related]
35. Sporadic Blau syndrome with onset of widespread granulomatous dermatitis in the newborn period.
Stoevesandt J; Morbach H; Martin TM; Zierhut M; Girschick H; Hamm H
Pediatr Dermatol; 2010; 27(1):69-73. PubMed ID: 20199415
[TBL] [Abstract][Full Text] [Related]
36. A novel nucleotide oligomerisation domain 2 mutation in a family with Blau syndrome: Phenotype and function.
Ong LT; Nachbur U; Rowczenio D; Ziegler JB; Fischer E; Lin MW
Innate Immun; 2017 Oct; 23(7):578-583. PubMed ID: 28836875
[TBL] [Abstract][Full Text] [Related]
37. Widespread granulomatous dermatitis of infancy: an early sign of Blau syndrome.
Schaffer JV; Chandra P; Keegan BR; Heller P; Shin HT
Arch Dermatol; 2007 Mar; 143(3):386-91. PubMed ID: 17372104
[TBL] [Abstract][Full Text] [Related]
38. Insights into the molecular basis of the NOD2 signalling pathway.
Boyle JP; Parkhouse R; Monie TP
Open Biol; 2014 Dec; 4(12):. PubMed ID: 25520185
[TBL] [Abstract][Full Text] [Related]
39. A novel mutation in the NOD2 gene associated with Blau syndrome: a Norwegian family with four affected members.
Milman N; Ursin K; Rødevand E; Nielsen FC; Hansen TV
Scand J Rheumatol; 2009; 38(3):190-7. PubMed ID: 19169908
[TBL] [Abstract][Full Text] [Related]
40. Unique Variant of NOD2 Pediatric Granulomatous Arthritis With Severe 1,25-Dihydroxyvitamin D-Mediated Hypercalcemia and Generalized Osteosclerosis.
Whyte MP; Lim E; McAlister WH; Gottesman GS; Trinh L; Veis DJ; Bijanki VN; Boden MG; Nenninger A; Mumm S; Buchbinder D
J Bone Miner Res; 2018 Nov; 33(11):2071-2080. PubMed ID: 29933504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
